CINECA IRIS Institutional Research Information System

ELIA, GIUSY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.772
AS - Asia 2.860
EU - Europa 2.530
SA - Sud America 582
Continente sconosciuto - Info sul continente non disponibili 392
AF - Africa 165
OC - Oceania 10
Totale 12.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.604
IT - Italia 1.084
SG - Singapore 888
CN - Cina 743
BR - Brasile 481
HK - Hong Kong 444
SE - Svezia 413
VN - Vietnam 332
DE - Germania 218
BG - Bulgaria 128
FR - Francia 125
GB - Regno Unito 118
FI - Finlandia 111
CA - Canada 102
RU - Federazione Russa 93
IN - India 80
NL - Olanda 67
IQ - Iraq 56
TR - Turchia 54
JP - Giappone 53
CI - Costa d'Avorio 51
BD - Bangladesh 42
MX - Messico 36
AR - Argentina 34
AT - Austria 29
PL - Polonia 29
SN - Senegal 27
ZA - Sudafrica 23
ES - Italia 22
NG - Nigeria 22
UA - Ucraina 22
KR - Corea 20
SA - Arabia Saudita 19
EC - Ecuador 16
PK - Pakistan 15
CH - Svizzera 14
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 13
PH - Filippine 13
UZ - Uzbekistan 13
PY - Paraguay 11
VE - Venezuela 11
IE - Irlanda 10
AU - Australia 9
CZ - Repubblica Ceca 8
JO - Giordania 8
KE - Kenya 8
GR - Grecia 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
LT - Lituania 6
TH - Thailandia 6
UY - Uruguay 6
BY - Bielorussia 5
IR - Iran 5
PS - Palestinian Territory 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
GT - Guatemala 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
NP - Nepal 4
TT - Trinidad e Tobago 4
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
BS - Bahamas 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GY - Guiana 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
Totale 11.907
Salva come PNG Salva come JPEG
Città #
Ashburn 647
Dallas 530
Singapore 525
Fairfield 447
San Jose 442
Hong Kong 432
Santa Clara 407
Woodbridge 265
Milan 245
Chandler 229
Pisa 228
Houston 193
Shanghai 186
Seattle 182
Cambridge 162
Wilmington 147
Serra 145
New York 132
Council Bluffs 130
Sofia 128
Ann Arbor 126
Los Angeles 126
Beijing 114
Ho Chi Minh City 90
Munich 88
Boardman 86
Princeton 82
Helsinki 66
London 56
Lauterbourg 55
Lawrence 55
Rome 55
Abidjan 51
Florence 51
Medford 49
Tokyo 49
Frankfurt am Main 47
Hanoi 44
Redondo Beach 40
São Paulo 37
Hefei 36
Ottawa 33
Buffalo 31
Turku 30
Dong Ket 28
Dakar 27
Istanbul 27
Boulder 26
Des Moines 23
Redwood City 23
San Diego 23
Warsaw 23
Columbus 22
Fuzhou 21
Nanjing 21
Bremen 20
Seoul 20
Lagos 19
Baghdad 18
Hyderabad 18
Nuremberg 18
Orem 18
Phoenix 18
Sulaymaniyah 18
Dearborn 17
Amsterdam 16
Brooklyn 16
Chennai 16
Chicago 16
Ogden 16
Paris 16
Rio de Janeiro 16
Vienna 16
Livorno 15
Montreal 15
Carrara 14
Johannesburg 14
Da Nang 13
Düsseldorf 13
Haiphong 13
Norwalk 13
The Dalles 13
Washington 13
Denver 12
Guangzhou 12
Quanzhou 12
Tashkent 12
Toronto 12
Baltimore 11
Tianjin 11
Changsha 10
Curitiba 10
Manchester 10
Catania 9
Chengdu 9
Dublin 9
Hải Dương 9
Memphis 9
Mexico City 9
Zurich 9
Totale 8.186
Salva come PNG Salva come JPEG
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 255
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 249
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 238
Molecular testing in the diagnosis of differentiated thyroid carcinomas 227
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 210
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 202
Mechanostructure and composition of highly reproducible decellularized liver matrices 200
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 196
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 194
New insight in endocrine-related adverse events associated to immune checkpoint blockade 193
Characterisation of liver matrices 192
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 191
Novel therapies for thyroid autoimmune diseases: An update 190
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 190
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 188
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 186
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 184
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 182
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 178
Novel treatments for anaplastic thyroid carcinoma 177
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 167
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 166
Liver derived decellularised matrices in bioreactors 165
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 164
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 164
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 163
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 162
Chemokines in thyroid autoimmunity 160
Liver decellularised matrices in Quasi-Vivo® bioreactors as in-vitro models of hepatic metabolism 160
Immune and inflammatory cells in thyroid cancer microenvironment 160
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 158
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 157
Novel treatment options for anaplastic thyroid cancer 156
Thyroid Autoimmunity and SARS-CoV-2 Infection 154
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 153
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 152
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer 151
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro 150
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 150
Novel Therapies for Thyroid Autoimmune Diseases 149
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results 149
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 148
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 148
Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells 146
The protective effect of myo-inositol on human thyrocytes 145
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 145
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose 144
Hypothyroidism and metabolic cardiovascular disease 144
Chemokines in hyperthyroidism 143
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 142
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 140
Molecular features of aggressive thyroid cancer 138
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 138
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study 137
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 136
The COVID-19, epidemiology, clinic and prevention 135
Thyroid Metastasis from Primary Breast Cancer 133
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 130
Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up 124
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 124
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 122
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 122
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 119
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 118
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 117
null 115
Teprotumumab for the treatment of thyroid eye disease 114
Precision Medicine in Graves’ Disease and Ophthalmopathy 113
Endocrine disruptors and thyroid autoimmunity 105
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 104
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 103
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 103
L-T4 Therapy in Enteric Malabsorptive Disorders 103
High risk of brain tumors in military personnel: a case control study 100
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 87
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 87
null 87
Thyroid autoimmune disorders and cancer 86
Myoinositol in Autoimmune Thyroiditis 74
null 73
Th1 chemokines in autoimmune endocrine disorders 69
COVID-19 AND CRYOGLOBULINEMIC VASCULITIS. LONG-TERM SURVEY STUDY ON THE IMPACT OF PANDEMIC AND VACCINATION ON A LARGE PATIENT'S POPULATION 63
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro 40
Autoimmune Thyroid Diseases and Epigenetics 32
Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications 25
Interferon-γ-induced protein 10 in Dengue virus infection 12
Leishmaniasis and IFN-γ dependent chemokines 11
Interferon-γ-Inducible chemokines in Systemic Lupus Erythematosus 11
Dermatomyositis and chemokines 10
MIG Th1 chemokine in Vitiligo 8
MIG in psoriatic arthritis 6
Totale 12.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022792 0 16 31 49 123 103 32 39 70 66 63 200
2022/2023907 137 128 74 53 74 104 38 53 153 6 67 20
2023/2024968 81 93 137 109 138 155 65 23 14 21 39 93
2024/20252.962 142 86 81 169 273 341 271 152 190 334 335 588
2025/20264.196 278 406 584 405 381 312 620 178 226 474 148 184
2026/2027185 159 26 0 0 0 0 0 0 0 0 0 0
Totale 12.311